Home
About
Overview
Sharing Data
ORCID
Help
History (5)
Addition of daratumumab to lenalidomide, bortezomib, and dexamethasone for transplantation-eligible patients with newly diagnosed multiple myeloma (GRIFFIN): final analysis of an open-label, randomised, phase 2 trial.
Advances in mobilization for the optimization of autologous stem cell transplantation.
Cardiovascular events during carfilzomib therapy for relapsed myeloma: practical management aspects from two case studies.
SpectralTDF: transition densities of diffusion processes with time-varying selection parameters, mutation rates and effective population sizes.
Transcriptome-wide reprogramming of N6-methyladenosine modification by the mouse microbiome.
See All 5 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Advances in mobilization for the optimization of autologous stem cell transplantation.
Advances in mobilization for the optimization of autologous stem cell transplantation. Leuk Lymphoma. 2009 Sep; 50(9):1412-21.
View in:
PubMed
subject areas
Antineoplastic Agents
Benzylamines
Calibration
Granulocyte Colony-Stimulating Factor
Granulocyte-Macrophage Colony-Stimulating Factor
Hematopoietic Stem Cell Mobilization
Heterocyclic Compounds
Humans
Immunologic Factors
Models, Biological
Rationalization
Stem Cell Transplantation
Transplantation, Autologous
authors with profiles
Koen Van Besien